Table 2.
Multivariable model evaluating risk of death among the entire patient cohort.
| Feature | Hazard ratio | 95% Confidence ratio | P Value |
|---|---|---|---|
| Cytoreductive nephrectomy | 0.33 | 0.24–0.45 | <0.0001 |
| Histology | |||
| Clear cell | 1.0 (reference) | - | - |
| Non-clear cell | 2.08 | 1.37–3.15 | 0.001 |
| Other/Unknown | 1.61 | 1.08–2.39 | 0.02 |
| Total metastatic sites | |||
| Only 1 | 1.0 (reference) | - | - |
| 2 or more | 1.09 | 0.81–1.47 | 0.6 |
| Age at metastatic diagnosis | 1.00 | 0.99–1.02 | 0.7 |
| IMDC risk score | |||
| Favorable | 1.0 (reference) | - | - |
| Intermediate | 1.24 | 0.65–2.38 | 0.5 |
| Poor | 2.28 | 1.13–4.61 | 0.02 |
| ICI utilization | |||
| First line | 1.0 (reference) | ||
| Second line or later | 1.03 | 0.7–1.53 | 0.9 |